Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4399 Urinary Bladder Neoplasms 1078 Carcinoma, Renal Cell 1041 Kidney Neoplasms 567 Breast Neoplasms 453 Neoplasms 403 Carcinoma, Transitional Cell 299 Neoplasm Metastasis 250 Lung Neoplasms 242 Testicular Neoplasms 202 Melanoma 195 Colorectal Neoplasms 193 Ovarian Neoplasms 163 Carcinoma, Non-Small-Cell Lung 150 Sarcoma 135 Non-Muscle Invasive Bladder Neoplasms 135 Pancreatic Neoplasms 124 Colonic Neoplasms 121 Head and Neck Neoplasms 116 Uterine Cervical Neoplasms 115 Wilms Tumor 108 Recurrence 106 Motor Activity 100 Stomach Neoplasms 89 Urologic Neoplasms 88 Neuroblastoma 88 Disease 85 Multiple Myeloma 83 Carcinoma, Hepatocellular 79 Adenocarcinoma 79

Interventions

tislelizumab 1 pamiparib 1 Injections 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locally Advanced Prostate Cancer × Genitourinary × Clear all

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡